We are live on ! Find out more
CORT icon

Corcept Therapeutics
CORT

207 hedge funds and large institutions have $1.26B invested in Corcept Therapeutics in 2018 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 86 increasing their positions, 64 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 64

1.21% more ownership

Funds ownership: 76.01% → 77.22% (+1.2%)

4% less funds holding

Funds holding: 215 → 207 (-8)

9% less capital invested

Capital invested by funds: $1.38B → $1.26B (-$121M)

21% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 34

46% less call options, than puts

Call options by funds: $6.35M | Put options by funds: $11.8M

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
207
Holders Change
-8
Holders Change %
-3.72%
% of All Funds
4.73%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
27
Increased
86
Reduced
64
Closed
34
Calls
$6.35M
Puts
$11.8M
Net Calls
-$5.46M
Net Calls Change
+$11.4M

Top Buyers

1
BlackRock
BlackRock
New York
+$21.6M
2
ISL
Ingalls & Snyder LLC
New York
+$15.1M
3
Invesco
Invesco
Georgia
+$13.4M
4
Morgan Stanley
Morgan Stanley
New York
+$9.96M
5
Stifel Financial
Stifel Financial
Missouri
+$6.63M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$19M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$13.4M
3
JIM
Jupiter Investment Management
United Kingdom
-$7.9M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$6.89M
5
NC
Nexthera Capital
New York
-$5.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fifth Third Bancorp
101
Fifth Third Bancorp
Ohio
$581K +$136K +9,701 +31%
EAM
102
Evanson Asset Management
California
$558K – – –
IA
103
Icon Advisers
Colorado
$557K +$555K +39,700 New
Creative Planning
104
Creative Planning
Kansas
$536K +$106K +7,586 +25%
Royal Bank of Canada
105
Royal Bank of Canada
Ontario, Canada
$535K +$528K +37,753 +3,775%
SGAM
106
Smith Group Asset Management
Texas
$526K -$830K -59,360 -61%
BPM
107
Bowling Portfolio Management
Ohio
$513K +$511K +36,581 New
CT
108
Cambridge Trust
Massachusetts
$502K – – –
CGH
109
Crossmark Global Holdings
Texas
$488K +$6.29K +450 +1%
SOADOR
110
State of Alaska Department of Revenue
Alaska
$479K +$40.9K +2,924 +9%
AA
111
ALPS Advisors
Colorado
$473K +$114K +8,139 +32%
TRSOTSOK
112
Teachers Retirement System of the State of Kentucky
Kentucky
$463K -$16.8K -1,200 -4%
FIM
113
Freedom Investment Management
Connecticut
$461K +$72K +5,151 +20%
MSA
114
Mason Street Advisors
Wisconsin
$439K +$51.3K +3,672 +13%
BCM
115
Bridgeway Capital Management
Texas
$435K – – –
MLICM
116
Metropolitan Life Insurance Company (MetLife)
New York
$434K – – –
GC
117
Globeflex Capital
California
$425K -$11.2K -800 -3%
CNAM
118
Campbell Newman Asset Management
Wisconsin
$387K +$385K +27,574 New
SRAM
119
Stone Ridge Asset Management
New York
$379K -$30.7K -2,200 -8%
William Blair & Company
120
William Blair & Company
Illinois
$379K – – –
Tudor Investment Corp
121
Tudor Investment Corp
Connecticut
$372K +$370K +26,500 New
COPPSERS
122
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$353K +$69.6K +4,979 +25%
QIM
123
Quantitative Investment Management
Virginia
$350K +$349K +25,000 New
Ohio Public Employees Retirement System (OPERS)
124
Ohio Public Employees Retirement System (OPERS)
Ohio
$346K +$344K +24,644 New
PIA
125
Piedmont Investment Advisors
North Carolina
$339K +$26.2K +1,874 +8%
3 4
5
6 7

CORT Hedge Fund Activity: Q3 2018 in Review

207 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Corcept Therapeutics (CORT) for Q3 2018, worth a combined $1.26B — down 8.8% from $1.38B a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of CORT and 27 opened new positions — a net loss of 7 holders — while 64 trimmed existing stakes and 86 added.

The largest buyer was BlackRock, adding an estimated $21.6M. The largest seller was Acadian Asset Management, cutting an estimated $19M.

  • 207 institutional investors held Corcept Therapeutics (CORT) as of Q3 2018, down from 215 in Q2 2018.
  • Funds reported $1.26B of Corcept Therapeutics stock for Q3 2018, down 8.8% quarter-over-quarter.
  • 27 funds opened new Corcept Therapeutics positions in Q3 2018 and 34 closed out, a net change of -7 holders.
  • The largest Corcept Therapeutics buyer in Q3 2018 was BlackRock, an estimated $21.6M added.
  • The largest Corcept Therapeutics seller in Q3 2018 was Acadian Asset Management, an estimated $19M sold.

Based on aggregated 13F filings for Q3 2018.